We are live on ! Find out more
MNA

Manning & Napier Advisors Portfolio holdings

AUM $7.09B
1-Year Est. Return 17.35%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+17.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.7B
AUM Growth
+$41.2M
Cap. Flow
-$475M
Cap. Flow %
-4.07%
Top 10 Hldgs %
28.8%
Holding
332
New
20
Increased
68
Reduced
204
Closed
12

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$112M
2
CRM icon
Salesforce
CRM
+$97.7M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$85.7M
4
AMX icon
America Movil
AMX
+$79.5M
5
ABEV icon
Ambev
ABEV
+$62.7M

Sector Composition

Rank Sector Weight
1 Healthcare 25.24%
2 Technology 11.76%
3 Consumer Discretionary 11.57%
4 Communication Services 9.35%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1
Medtronic
MDT
$106B
$411M 3.52%
5,289,068
+90,922
+2% +$7.55M
META icon
2
Meta Platforms (Facebook)
META
$1.53T
$380M 3.26%
2,225,794
-119,222
-5% -$19.9M
NVS icon
3
Novartis
NVS
$295B
$377M 3.23%
4,902,207
-418,572
-8% -$31.6M
NOW icon
4
ServiceNow
NOW
$101B
$376M 3.22%
15,987,645
-683,730
-4% -$15.2M
UL icon
5
Unilever
UL
$131B
$362M 3.1%
5,552,030
-750,850
-12% -$48.3M
ABEV icon
6
Ambev
ABEV
$47.9B
$347M 2.97%
52,662,595
-10,121,930
-16% -$62.7M
SLB icon
7
SLB Ltd
SLB
$77.6B
$336M 2.88%
4,810,802
-201,516
-4% -$13.3M
BKNG icon
8
Booking.com
BKNG
$138B
$300M 2.57%
4,090,325
-283,800
-6% -$21.5M
MON
9
DELISTED
Monsanto Co
MON
$242M 2.07%
2,017,223
-128,196
-6% -$15.1M
JNJ icon
10
Johnson & Johnson
JNJ
$633B
$231M 1.98%
1,778,271
-54,208
-3% -$7.19M
BIIB icon
11
Biogen
BIIB
$30B
$231M 1.98%
737,735
-76,634
-9% -$22.7M
V icon
12
Visa
V
$673B
$227M 1.94%
2,153,943
-358,937
-14% -$36.4M
SWKS icon
13
Skyworks Solutions
SWKS
$9.12B
$223M 1.91%
2,190,222
+186,077
+9% +$19.3M
FDX icon
14
FedEx
FDX
$75B
$218M 1.87%
967,775
-32,825
-3% -$6.99M
LULU icon
15
lululemon athletica
LULU
$13.1B
$214M 1.83%
3,437,706
-358,832
-9% -$21.6M
DVA icon
16
DaVita
DVA
$15.2B
$213M 1.83%
3,588,450
+1,874,974
+109% +$113M
MA icon
17
Mastercard
MA
$473B
$209M 1.79%
1,479,698
-130,808
-8% -$17.3M
TFCFA
18
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$203M 1.74%
7,696,039
-1,120,258
-13% -$30.9M
NLSN
19
DELISTED
Nielsen Holdings plc
NLSN
$198M 1.7%
4,781,759
-224,890
-4% -$8.98M
BMRN icon
20
BioMarin Pharmaceuticals
BMRN
$11.4B
$192M 1.65%
2,065,710
-52,776
-2% -$4.66M
PRGO icon
21
Perrigo
PRGO
$1.42B
$190M 1.62%
2,240,413
-345,655
-13% -$26.9M
DOX icon
22
Amdocs
DOX
$5.55B
$180M 1.54%
2,798,207
-199,545
-7% -$12.9M
AMZN icon
23
Amazon
AMZN
$2.51T
$179M 1.53%
3,715,140
-203,100
-5% -$9.98M
EA icon
24
Electronic Arts
EA
$52.4B
$173M 1.48%
1,465,586
-71,157
-5% -$8.24M
QRVO icon
25
Qorvo
QRVO
$7.68B
$173M 1.48%
2,443,052
+840,755
+52% +$58.6M

Similar funds

Manning & Napier Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Manning & Napier Advisors held 332 positions worth $11.7B, up 0.35% from $11.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Manning & Napier Advisors withdrew a net $475M in Q3 2017, closing 12 positions and reducing 204 holdings. Its most notable exit was Liberty Global Class A, an estimated $85.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Manning & Napier Advisors opened a new position in Incyte worth $125M.

  • Manning & Napier Advisors's largest Q3 2017 buy was Incyte: 1,071,325 shares worth $125M.
  • Manning & Napier Advisors added most to DaVita in Q3 2017, an estimated $113M increase.
  • Manning & Napier Advisors's biggest Q3 2017 reduction was Vertex Pharmaceuticals, cutting an estimated $112M.
  • Manning & Napier Advisors fully exited Liberty Global Class A in Q3 2017, selling an estimated $85.7M.
  • Manning & Napier Advisors's ten largest holdings make up 29% of its $11.7B portfolio in Q3 2017.
  • Manning & Napier Advisors opened 20 new positions and closed 12 in Q3 2017.
  • Manning & Napier Advisors's portfolio value rose 0.35% quarter-over-quarter to $11.7B.

Based on Manning & Napier Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.